Carevive ACCC Business Summit

Carevive made a significant impact at the ACCC Business Summit held in Washington DC. John Elliott, representing Carevive, expressed excitement about being present at the in-person conference and highlighted the organization’s dedication to improving patient outcomes and experiences. Carevive’s partnership with UT-Austin Dell Medical School Cancer Institute was a key focus, promising exciting developments in the coming years.

Partnership Announcement and Future Prospects:

Carevive unveiled its partnership with Care About, generating anticipation and enthusiasm among attendees. The collaboration promises to deliver remarkable advancements in patient care. Tomorrow’s presentation on the evaluation of Carevive’s integrated person volunteer program further piqued interest, and attendees were urged to log into the Life’s platform for future updates.

Sessions and Insights:
The ACCC Business Summit offered a range of sessions focused on enhancing asthma care, utilizing data for improvement, and enhancing the patient experience. Carevive participants eagerly looked forward to Thursday’s session and expressed their commitment to keeping attendees informed in real-time.

Recent Episodes

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…